Please use this identifier to cite or link to this item: https://rima.ufrrj.br/jspui/handle/20.500.14407/14205
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFreitas, Rosemar de Almeida
dc.date.accessioned2023-12-22T02:57:27Z-
dc.date.available2023-12-22T02:57:27Z-
dc.date.issued2019-02-14
dc.identifier.citationFreitas, Rosemar de Almeida. Estadiamento da doença renal crônica em cães domésticos (Canis familiaris, linnaeus, 1758) com doença valvar crônica. 2019. [87 f.]. Dissertação( Programa de Pós-Graduação em Medicina Veterinária (Patologia e Ciências Clínicas)) - Universidade Federal Rural do Rio de Janeiro, [Seropédica-RJ] .por
dc.identifier.urihttps://rima.ufrrj.br/jspui/handle/20.500.14407/14205-
dc.description.abstractA insuficiência cardíaca acarreta, à curto ou longo prazo, em perda da capacidade renal de manter a homeostase. Esta interrelação de lesão mútua, denominada de síndrome cardiorrenal, já é amplamente estudada na medicina, entretanto, na veterinária os estudos ainda são incipientes. Sendo assim, faz-se necessária a atenção maior sobre o assunto já que ambas as doenças estão dentre as principais causas de óbito em cães geriatras. O objetivo do estudo foi determinar a ocorrência da doença renal crônica em cães com doença valvar crônica por meio de exames laboratoriais e exame de imagem; estadiando e subestadiando-os segundo a International Renal Interest Society. Fizeram parte do estudo 23 cães, entre machos e fêmeas de idades diversas, com diagnóstico ecocardiográfico de doença valvar crônica. Todos estes cães após serem estadiados quanto ao grau de comprometimento valvar (estágios B1, B2 e C), foram submetidos à avaliação clínica nefrológica com posterior coleta de amostras biológicas (sangue e urina), exame de imagem (ultrassonografia) e mensuração da pressão arterial sistólica sistêmica com intuito de investigar lesão renal prévia. Neste estudo não foram admitidos cães em estágio A (pré-dispostos) e em estágio D (em tratamento), pois a existência de degeneração valvar e ausência de uso fármacos que viessem a interferir na função e/ou perfusão renal, foram utilizados como critérios de inclusão. Nos resultados obtidos, pode ser observado que as fêmeas foram mais acometidas que os machos, a raça poodle foi a mais diagnosticada com a doença valvar crônica e que no estágio 1 da doença renal crônica esteve presente na maior parte dos cães (15/23) nos diferentes estágios da doença valvar crônica. Ao subestadiar estes cães quanto à proteinúria, pode ser observado que esta esteve presente em sua maioria nos cães em estágio C da doença valvar crônica. Quanto ao risco de lesão em órgão alvo segundo a mensuração da pressão arterial sistólica sistêmica, pode ser observado que independente do estágio da doença valvar crônica, os cães deste estudo encontravam-se na sua maioria em risco mínimo de desenvolvimento de lesão em órgão alvo. A predominância de cães em estágio C com doença renal crônica, pode ser justificada pelo déficit na perfusão renal, secundário à redução do débito cardíaco. Pode se concluir através deste estudo que a doença renal crônica é um achado comum em cães com doença valvar crônica.por
dc.formatapplication/pdf*
dc.languageporpor
dc.publisherUniversidade Federal Rural do Rio de Janeiropor
dc.rightsAcesso Abertopor
dc.subjectinsuficiência cardíaca congestivapor
dc.subjectsíndrome cardiorrenalpor
dc.subjectcãopor
dc.subjectcongestive heart failureeng
dc.subjectcardio-renal syndromeeng
dc.subjectdogeng
dc.titleEstadiamento da doença renal crônica em cães domésticos (Canis familiaris, linnaeus, 1758) com doença valvar crônicapor
dc.title.alternativeStaging of chronic kidney disease in domestic dogs (canis familiaris, Linnaeus, 1758) with valve chronic diseaseeng
dc.typeDissertaçãopor
dc.description.abstractOtherHeart failure causes, short or long term, in loss of kidney ability to maintain homeostasis. This interrelation of mutual injury, called cardiorenal syndrome, is already widely studied in medicine, however, there are few studies in veterinary, making it necessary to increased attention on the issue given that both diseases are the most common cause of death in geriatric dogs. The aim of the study was to determine the occurrence of chronic kidney disease in dogs with chronic valve disease through laboratory tests and imaging exams; staging and substaging them according to the International Renal Interest Society. In total 23 dogs participated in the study males and females of various ages, with echocardiographic diagnosis of chronic valve disease. All of these dogs after being staged in the degree of valve disease (stages B1, B2 and C), underwent clinical assessment of renal function with subsequent collection of biological samples (blood and urine), imaging exam (ultrasound) and measurement of blood pressure systolic systemic aiming to investigate previous renal injury. In this study were not include dogs in stage A (pre-arranged) and D stage (in treatment) because as inclusion criterion that the existence of valve degeneration and absence of drug use that were to interfere with the kidney function and /or perfusion. The results obtained, showed that females were more affected than males; the poodle was the breed with most diagnostic of chronic valve disease and that in stage 1 of chronic kidney disease was present in most dogs (15/23) in different stages of chronic valve disease. When these dogs were substaged as the degree of proteinuria, it could be seen that this was present mostly in dogs in stage C of chronic valve disease. The risk of injury in target organ after the measurement of the systemic systolic blood pressure, it was noted that regardless of the stage of chronic valve disease, the dogs of this study were in the majority in minimal risk of developing target organ damage. The predominance of dogs in stage C with chronic kidney disease, can be explained by the deficit in renal perfusion secondary to reduced cardiac output. It can be concluded through this study that chronic kidney disease is a common finding in dogs with chronic valve diseaseeng
dc.contributor.advisor1Paiva, Jonimar Pereira
dc.contributor.advisor1ID02343172722por
dc.contributor.advisor1Latteshttp://lattes.cnpq.br/0555358847663175por
dc.contributor.referee1Nobre e Castro, Maria Cristina
dc.contributor.referee2Fernandes, Julio Israel
dc.contributor.referee3Baldani, Cristiane Divan
dc.creator.ID05513247755por
dc.creator.Lattes: http://lattes.cnpq.br/4384602180919201por
dc.publisher.countryBrasilpor
dc.publisher.departmentInstituto de Veterináriapor
dc.publisher.initialsUFRRJpor
dc.publisher.programPrograma de Pós-Graduação em Medicina Veterinária (Patologia e Ciências Clínicas)por
dc.relation.referencesABBOTT, J. A. Valvulopatia degenerativa. In: ABBOTT, J. A. Segredos em cardiologia de pequenos animais. Porto Alegre: Artmed, p. 281-96, 2006. ABBOTT, J. A. Acquired Valvular Disease. In: TILLEY, L. P.; FRANCIS, W. K.; SMITH, J.; OYAMA, M. A.; SLEEPER, M. M. Manual of canine and feline cardiology, 4ed ed. St Louis, Mo.: Elsevier Saunders, p. 110-138, 2008. ACIERNO, M. J.; LABATO, M. A. Hipertension in renal disease: diagnosis and treatment. Clinical techniques in small animal practice, Philadelphia, v. 20, p. 23-30, 2005. ALBASAN, H.; LULICH, J. P.; OSBORNE, C.A.; LEKCHAROENSUK, C.; ULRICH, L. K.; CARPENTER, K. A. Effects of storage time and temperature on pH, specific gravity, and crystal formation in urine samples from dogs and cats. Journal of the American Veterinary Medical Association, n. 222, p. 176-179, 2003. AMBERGER, C.; GLARDON, O.; LOMBARD, C. W. Validité des examens complementaires dans l’evaluation de l’insuffisance cardiaque par endocardiose mitrale. Pratique Medicale and Chirurgicale de l’animal de Compagnie, n. 30, p. 659-670, 1995. ATKINS, C. E. Acquired valvular insufficiency. In: MILLER, M. S.; TILLEY, L. P. Manual of canine and feline cardiology. ed. 2, Philadelphia: Saunders, p. 129-144, 1995. ATKINS, C. E.; BROWN, W. A.; COATS, J. R.; CRAWFORD, M. A.; DEFRANCESCO, T. C.; EDWARDS, J.; FOX, P. R.; KEENE, B. W.; LEHMKUHL, L.; LUENTHY, M.; MEURS, K.; PETRIE, J. P.; PIPERS, F.; ROSENTHAL, S.; SIDLEY, J. A.; STRAUS, J. Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation. Journal of the American Veteterinary Medical Association, n. 221, p. 654–658, 2002. ATKINS, C.; BONAGURA, J.; ETTINGER, S.; FOX, P.; GORDON S.; HAGGSTROM, J. Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. Journal of Veterinary Internal Medicine. n. 6, p. 1142-1150, 2009. ÁVILA, D. F.; RESENDE, M. C. O.; SANTOS, N. B.; MARTINS, A. N.; TEIXEIRA, J. R.; TEIXEIRA, P. A. Levantamento as cadiopatias em cães durante vinte anos de necropsias. Disponível em http://wwwsovergs.com.br/conbravet2008/anais/cd/resumos/ R0770-2.pdf. Acesso em: 20/12/14. BACIC, A.; KOGIKA, M. M.; BARBARO, K. C.; LUAMOTO, C. S; SIMÕES, D. M.; SANTORO, M. L. Evaluation of albuminuria and its relationship with blood pressure in dogs with chronic kidney disease. Veterinary Clinical Pathology, n. 32, p.1-7, 2010. 65 BAKRIS, G. L.; WIER, M. R. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Archives of Internal Medicine, n. 160, p. 685–693, 2000. BARBER, P. J.; ELLIOT, J. Assessment of Parathyroid functions in Renal failure. In: BAINBRIDGE, J.; ELLIOT, J. Manual of Canine and Feline Nephrology and Urology. BSAVA, cap. 8, p.117-123, 1996. BARGSHAW, S. M.; CRUZ, D. M.; ASPROMONTE, N.; DALIENTO, L.; RONCO, F. Epidemiology for the Acute Dialysis Quality Initiative (ADQI) Consensus Group. Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrology Dialysis Transplantation. n.25, p. 1406–1416, 2010. BARTGES, J. W. Chronic kidney disease in dog and cats. Veterinary Clinics North America small animal practice, v.42, p.669-692, 2012. BELERENIAN, G. C.; MUCHA, C. J.; CAMACHO, A. A. Afecções Cardiovas-culares em Pequenos Animais. São Paulo: Interbook, p. 146-151, 2003. BELEW, A. M.; BARLETT, T.; BROWN, S. A. Evaluation of the whitecoat effect in cats. Journal of Veterinary Internal Medicine, n. 13, p. 134–142, 1999. BHATIA, R. S.; TU, J. V.; LEE, D. S.; AUSTIN, P. C.; FANG, J.; HAOUZI, A. Outcome of heart failure with preserved ejection fraction in a population-based study. The New England Journal of Medicine. n. 3, p. 260-269, 2006. BLACK, A.; FRENCH, A. T.; DUKES-MCEWAN, J.; CORCORAN, B. M. Ultrastructural morphologic evaluation of the phenotype of valvular interstitial cells in dogs with myxomatous degeneration of the mitral valve. American Journal Veterinary Research. v. 66, n. 8, p. 1408-1414, 2005. BLAIR, J. E.; MANUCHEHRY, A.; CHANA, A.; ROSSI, J.; SCHRIER, R. W.; BURNETT, J. C. Prognostic markers in heart failure--congestion, neurohormones, and the cardiorenal syndrome. Acute Cardiology Care. v. 9, n. 4, p. 207-213, 2007. BONAGURA, J. D. Cardiovascular Diseases. In: SHERDING, R. G. The Cat Diseases and Clinical Management. Churchill Livinstone, 2 ed., v. 1, p. 434-499, 1994. BONAGURA, J. D.; MILLER, M. W. Doppler echocardiography. Color Doppler imaging. Veterinary Clinics North America Small Animal Practice. v.28, n. 6, p. 1361-1389, 1998. BONGARTZ, L. G.; CRAMER, M. J.; DOEVENDANS, P. A.; JOLES, J. A.; BRAAN, B. The severe cardiorenal syndrome: ‘Guyton revisited’. European Heart Journal. n. 26, p. 11–17, 2005. BOON, J. A. Acquired heart disease. In: BOON, J. A. Manual of Veterinary Echocardiography. Wiley-Blackwell, 3 ed., p. 261-382, 2011. 66 BORGARELLI, M.; ZINI, E.; D´AGNOLO, G.; TARDUCCI, A.; SANTILLI, R. A.; CHIAVEGATO, D.; TURSI, M. Comparison of primary mitral valve disease in German Shepherd dogs and in small breeds. Journal Veterinary Cardiology. v. 6, n. 2, p. 27-34, 2004. BORGARELLI, M.; SAVARINO, P.; CROSARA, S.; SANTILLI, R. A.; CHIAVEGATO, D.; POGGI, M. Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. Journal of Veterinary Internal Medicine. n. 22, p. 120-128, 2008. BORGARELLI, M.; BUCHANAN, J. M. Historical review, epidemiology and natural history of degenerative mitral valve disease. Journal of Veterinary Cardiology. n. 14, p. 93-101, 2012. BRAAM, B.; CUPPLES, W. A.; JOLES, J. A.; GAILLARD, C. Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure. Heart Failure Reviews; n. 17, p. 161–175, 2012. BRANTSMA, A. H.; BAKKER, S. J.; DE ZEEUW, D.; DE JONG, P. E.; GANSEVOORT, R. T. Extended prognostic value of urinary albumin excretion for cardiovascular events. Journal of the American Society of Nephrology, Baltimore, v. 19, n. 9, p. 1785-1791, 2008. BRAUN, J. P.; LEFEBVRE, H. P.; WATSON, A. D. J. Creatinine in the dog: A review. Veterinary Clinical Pathology, v. 32, n. 4, p. 162-179, 2003. BRISTOW, M. R. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. Journal Molecular and Cellular Cardiology. v. 33, n. 5, p. 887– 905, 2001. BROWN, S.; ATKINS, C.;CARR, A. R.; COWGILL, L.; DAVIDSON, M.; EGNER, B.; ELLIOT, J.; HENIK, R.; LOBATO, M.; LITTMAN, M.; POLZIN, D.; ROSS, L.; SNYDER, P.; STEPIEN, R. Guidelines for the Identification, Evaluation, and Management of Systemic Hypertension in Dogs and Cats. Journal of Veterinary Internal Medicine. v.21, p. 542-558, 2007. BROWN, S.; CHAIR, J.; ELLIOTT, J.; FRANCEY, T.; POLZIN, D.; VADEN, S. Consensus Recommendations for Standard Therapy of Glomerular Disease in Dogs: IRIS Canine GN Study Group Standard Therapy Subgroup. Consensus Statement. Journal of Veterinary Internal Medicine, n. 27, p. 27-43, 2013. BRUM, P.C.; KOSEK, J.; PATTERSON, A.; BERNSTEIN, D.; KOBILKA, B. Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice. American Journal of Physiology. Heart Circ. Physiol., v. 283, n. 5, p. 1838–1845, 2002. BUCHANAN, J. W. Chronic valvular disease (endocardiosis) in dogs. Advances in Veterinary Science & Comparative Medicine. v. 21, p. 75-106, 1977. 67 BUCHANAN, J. W.; BUCHELER, J. Vertebral scale system to measure canine heart size in radiographs. Journal of the American Veterinary Medical Association. v. 206, n. 2, p. 194-199, 1995. BUCHANAN, J. W. Prevalence of cardiovascular disorders. In: MOISE, N. S.; FOX P. R.; SISSON, D. Canine and feline cardiology – principles and clinical practice. 2ed. Philadelphia: Saunders, p. 457-70, 1999. BURNS, W. C.; THOMAS, M. C. Angiotensin II and its role in tubular epithelial to mesenchymal transition associated with chronic kidney disease. Cells Tissues Organs. n. 193, p. 74–84, 2011. BUSHINSKY, D. A.; MONK, R. D. Calcium. Lancet. n. 352, p. 306-311, 1998. CADNAPAPHORNCHAI, M. A.; GUREVICH, A. K.; WEINBERGER, H. D.; SCHRIER, R. W. Pathophysiology of sodium and water retention in heart failure. Cardiology. v. 96, n. 3, p. 122-131, 2001. CARR, A. P.; EGNER, M. A. Cardiopatia em cães e gatos. In: HOSKINS, J. D. Geriatria e Gerontologia do Cão e do Gato. 2d, São Paulo:Roca, cap. 8, p. 141-166, 2009. CHATTERJEE, K. Neurohormonal activation in congestive heart failure and the role of vasopressin. American Journal Cardiology. v. 95, n. 9, p.8-13, 2005. CHEW, D. J.; DIBARTOLA, S. P. Diagnóstico e fisiopatologia da moléstia renal. In: ETTINGER S. J. Tratado de Medicina Interna Veterinaria: moléstias do cão e gato. Manole:São Paulo, ed. 3, cap. 12, p. 1975-2046, 1992. CHEW, D. J.; BIBARTOLA, S. P.; SCHENCK, P. A. Urologia e Nefrologia do Cão e do Gato. 2 ed.; Cap. 5., p.145-196, 2011. CICOIRA, M.; ZANOLLA, L.; FRANCESCHINI, L.; ROSSI, A.; GOLIA, G.; ZENI, P.; CARUSO, B.; ZARDINI, P. Relation of aldosterone “escape” despite angiotensinconverting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. American Journal Cardiology. v. 89, n. 8, p. 403–407, 2002. CODY, R. J.; TORRES, S.; CLARK, M.; PONDOLFINO, K. Age-related hemodynamic, renal, and hormonal differences among patients with congestive heart failure. Archives of Internal Medicine. v. 149, n. 5, p. 1023-1028, 1988. COWGILL, L. D.; ELLIOTT, D. A. Insuficiência renal aguda. In: ETTINGER, S. J.; FELDMAN, E. C. Tratado de medicina interna veterinária – doenças do cão e do gato, Guanabara Koogan, ed. 5, p. 1701-1720, 2004. CREEMERS, E. E.; PINTO, Y. M. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovascular Research. v. 89, n. 4, p. 265–72, 2011. 68 CRUZ, D. N.; SCHMIDT-OTT, K. M.; VESCOVO, G.; HOUSE, A. A.; KELLUN, J. A.; RONCO, C.; MCCULLOUGH, P. A. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contributions Nephrology. v. 182, n. 5, p. 117–136, 2013. CUNNINGHAM, J. G.; KLEIN, B. G. Mecanismos Neuro-Hormonais. In: CUNNINGHAM, J. G.; KLEIN, B. G. Tratado de Fisiologia Veterinária. Elsevier Saunders, 3ed., p. 156-179, 2009. DAMMAN, K.; NAVIS, G.; VOORS, A. A.; ASSELBERGS, F. W.; SMILDE, T. D.; CLELAND, J. G.; VAN VELDHUISEN, D. J.; HILLEGE, H. L. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. Journal of Cardiac Failure. v. 13, p. 599–608, 2007. DAMMAN, K.; VAN VELDHUISEN, D. J.; NAVIS, G.; VOORS, A. A.; HILLEGE, H. L. Increased Central Venous Pressure Is Associated With Impaired Renal Function and Mortality in a Broad Spectrum of Patients With Cardiovascular Disease. Journal of the American College of Cardiology. v.53, n. 7, p. 582-588, 2009. DE SILVA, R.; LOH, H.; RIGBY, A. S.; NIKITIN, N. P.; WITTE, K. K.; GOODE, K.; BHANDARI, R.; NICHOLSON, A.; CLARK, A. L.; CLELAND, J. G. Epidemiology, associated factors, and prognostic outcomes of renal artery stenosis in chronic heart failure assessed by magnetic resonance angiography. American Journal Cardiology. v.100, n.2, p. 273–279, 2007. DIBARTOLA, S. P. Abordagem clínica e avaliação laboratorial da doença renal. In: STEPHEN, J.; ETTINGER, E.; FELDMAN, C. Tratado de medicina interna veterinária – doenças do cão e do gato, Guanabara Koogan, ed. 5, cap. 12, p. 1686- 1700, 2004. ELLIOTT, J.; BARBER, P. J. Feline chronic renal failure: clinical findings in 80 cases diagnosed between 1992-1995. Journal of Small Animal Practice. v. 39, p. 78-85, 1998. ELLIOTT, J. Plyuria/Polydipsia. In: Manual of canine and feline nephrology and urology. BRAINBRIDGE, J.; ELLIOTT, J. p. 28-41, BSAVA publications, Cheltenham, 1996. ELLIOTT, J.; GRAUER, G. F. "Proteinuria". BSAVA Manual of Canine and Feline Nephrology and Urology, ed. 2, ELLIOTT, J. E.; GRAUER, G. F. BSAVA, p. 69-78, 2007. ELLIOTT, J.; WATSON, A. D. J. Chronic kidney disease: staging and management. In: BONAGURA, J. D.; TWEDT, D. C. Kirk`s current veterinary therapy XIV. St. Louis, Missouri: Saunders Elsevier, p. 883-891, 2009. EPSTEIN, M. Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications. American Journal Kidney Diseases. v. 37, n. 4, p. 677-688, 2001. 69 EREN, Z.; OZVEREN, O.; BUVUKONER, E.; KASPAR, E.; DEGERTEKIN, M.; KANTARCI, G. A singlecentre study of acute cardiorenal syndrome: incidence, risk factors and consequences. Cardiorenal Medicine. v. 2, n. 3, p. 168–76, 2012. FAVUS, M. J.; LANGMAN, C. B. Evidence for calcium-dependent control of 1,25- dihydroxyvitamin D3 production by rat kidney proximal tubules. Journal of Biology Chemestry, n. 261, p. 24-26, 1986. FETTMAN, M. J.; REBAR, A. Laboratory evaluation of renal function. In: THRALL, M. A.; BAKER, D. C.; CAMPBELL, R. W.; DENICOLA, D.; FETTMAN, M. J.; LASSEN, E. D.; REBAR, A.; WEISER, G. Veterinary hematology and clinical chemistry. Filadelfia: Lippincott Willians & Wilkins, cap.21, p. 301-314, 2004. FINCO, D. R. Evaluation of renal functions. In: OSBORNE, C. A.; FINCO, D. R. Canine and feline nephrology and urology. Filadelfia: Lippincott Willians & Wilkins, cap.10, p. 216-228, 1995. FORMAN, D. E.; BUTLER, J.; WANG, Y.; ABRAHAM, W. T.; O`CONNOR, C. M.; GOTTLIEB, S. S.; LOH, E.; MASSIE, B. M.; RICH, M. W.; STEVENSON, L. W.; YOUNG, J. B.; KRUMHOLZ, H, M. Incidence, predictorsat admission, and impact of worsening renal function amongpatients hospitalized with heart failure. Journal American College Cardiology. v. 43, n. 7, p. 61-77, 2004. FOX, P. R. Cardiovascular History and Physical Examination Made Easy. In: North American Veterinary Conference Orlando, Florida, January 13-27, 2007. Disponível em. Acesso em: 15 dez. 2014. FRANCIS, G. S.; TANG, W. H. Pathophysiology of Congestive Heart Failure. Reviews. Cardiovascular Medicine. v. 4, p. 14-20, 2003. FROMMER, J. P.; KURTZMAN, N. A. Water and electrolyte abnormalities in chronic renal failure. In: EKNOYAN, G.; KNOCHEL, J. P. The systemic consequences of renal failure. Grune and Stratton, Orland, p. 405-420, 1984. FUJII, Y.; ORITO, K.; MUTO, M.; WAKAO, Y. Modulation of the tissue reninangiotensin-aldosterone system in dogs with chronic mild regurgitation through the mitral valve. American Journal of Veterinary Research, n. 68, p. 1045-1050, 2007. GRAUER, G. F.; GRECP, D. S.; GETSY, D. M.; COWGILL, L. D.; VADEN, S. L.; CHEW, D. J.; POLZIN, D. J.; BARSANTI, J. A. Effects of enalapril vs placebo as a treatment for canine idiopathic glomerulonefrites. Journal Veterinary Internal Medicine. v. 14, p. 526- 528, 2000. GRAUER, G. F. Measurement, Interpretation, and Implication of proteinuria and albuminúria. Veterinary Clinics of North America: Small Animal Practice, v. 37, p. 283-295, 2007. GRAUER, G. F. Urinary tract disorders In: COUTO, G. G.; NELSON, R. W. Small Animal Internal Medicine. Elsevier by Mosby, 4ed, cap. 8, p. 89-94, 2009. 70 GRAUER, G. F. Measurement, interpretation, and implications of proteinuria and albuminúria. Veterinary Clinics of North America: Small Animal Practice, v.37, p.283-295, 2010. GRAUER, G. F. Proteinuria: measurement and Interpretation. Topics in Companion animal medicine, v. 28, n.3, p. 121-127, 2011. GREGORY, C. R. Urinary system. In: LATIMER, K. S.; MAHAFFEY, E. A.; PRASSE, K. W. Veterinary laboratory medicine: clinical patology. Filadelfia: Blackwell Publishing Company, cap.9. p.231-257, 2003. GOLDSTON, R. T.; HOSKINS, J. D. Introdução e revisão de geriatria. In: Geriatria e Gerontologia do cao e do gato. São Paulo: Roca, p. 126-159, 1999. GUAZZI, M.; GATTO, P.; GIUSTI, G.; PIZZAMIGLIO, F.; PREVITALI, I.; VIGNATI, C.; ARENA, R. Pathophysiology of cardiorenal syndrome in decompensated heart failure: Role of lung-right heart-kidney interaction. International Journal of Cardiology, v. 169, n. 6, p. 379-384, 2013. HÄGGSTRÖM, J. Chronic valvular disease in Cavalier King Charles Spaniels: epidemiology, inheritance and pathophysiology. Thesis. Uppsala: Swedish University of Agriculture Sciences, 1996. HAGGSTROM, J. New insights into degenerative mitral valve disease in dogs. Journal of Veterinary Cardiology. v. 6, n. 2, p. 6-7, 2004. HÄGGSTRÖM, J.; HÖGLUND, K.; BORGARELLI, M. An update on treatment and prognostic indicators in canine myxomatous mitral valve disease. Journal of Small Animal Practice. v. 50, n. 1, p. 25–33, 2009. HÄGGSTRÖM, J. Myxomatous mitral valve disease. In: FUENTES, V. L.; JOHNSON, L. R.; DENNIS, S. Manual of Canine and Feline Cardiorespiratory Medicine. BSAVA, p. 186-194, 2010. HANADA, S.; TAKEWA, Y.; MIZUNO, T.; TSUKIYA, T.; TAENAKA, Y.; TATSUMI, E. Effect of the technique for assisting renal blood circulation on ischemic kidney in acute cardiorenal syndrome. Journal of Artificial Organs. v.15, n. 8, p. 140– 145, 2012. HEBERT, K.; DIAS, A.; DELGADO, M. C.; FRANCO, E.; TAMARIZ,L.;STEEN, D.; TRAHAN, P.; MAJOR, B.; LEE, M. Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population. European Journal Heart Failure. v. 12, n. 8, p. 861–865, 2010. HIBBERT, J. M.; FORRESTER, T.; JACKSON, A. A. Urea kinetics: Comparison of oral and intravenous dose regimens. European Journal Clinical Nutrition. v. 46, p. 405– 409, 1992. HOSKINS, J. D. Geriatria e gerontologia do cao e do gato. 2 ed., São Paulo: Roca, p. 437-440, 2008. 71 HUTCHINSON, F.; JONES, W. A. cost-effectiveness analysis of anemia screening before erythropoietin in patients with end-stage renal disease. American of Journal Kidney Disease, v. 56, p. 345-347, 1997. IRIS. Staging of CKD, 2013. Disponível em: htt://www.iriskidney.com/guidelines/en/ staging/ckd.shtml Acesso em 12 dez., 2014. JACOB, F.; POLZIN, D. J.; OSBORNE, C. A.; NEATON, J. D.; KIRK, C. A.; ALLEN, T. A.; SWANSON,L. Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure. Journal of American Veterinary Medical Association. v. 226, n. 6, p. 393–400, 2005. JACKSON, A. A.; PICOU, D.; LANDMAN, J. The non-invasive measurement of urea kinetics in normal man by a constant infusion of 15N15N-urea. Human Nutrition Clinical Nutrition. v.38, n. 6, p. 339–354, 1984. JÚNIOR, J.; CANZIANI, M.; BARRETTI, P. Anemia na insuficiência renal crônica: novas tendências. Jornal Brasileiro de Nefrologia, n. 34, p. 56-60, 1999. KANEKO, J. J.; HARVEY, J. W.; BRUSS, M. L. Clinical Biochemistry of Domestic Animals. San Diego: Academic Express, 6 ed., p. 936, 1998. KEENE, B. W. Chronic Valvular Disease in the Dog. In: FOX, P. Canine and Feline Cardiology. Churchill Livingstone, 2 ed., p. 409-418, 1988. KLABUNDE, R. Neuro-Hormonal Activation. In: KLABUNDE, R. Cardiovascular Physiology Concepts. Lippincott Williams & Wilkins. p. 89-93, 2011. KIENLE, R. D.; THOMAS, W. P. Ecocardiografia. In: NYLAND, T. G.; MATTOON, J. S. Ultrassom diagnóstico em pequenos animais. 2.ed. São Paulo: Roca, p.365-438, 2005. KITTLESON, M.; KIENLE, R. Myxomatous Atrioventricular Valvular Degeneration. In: KITTLESON, M.; KIENLE, R. Small Animal Cardiovascular Medicine. 2ed., p. 297- 317, 1998. KITTLESON, M. D. Myxomatous Atrioventricular Valvular Degeneration Small Animal Cardiovascular Medicine Textbook. 2010. Disponível em: http://www.vin.com/ Members/proceedings/Proceedings.plx?CID=SACARDIO&Category=1613&PID=13472 &O=VIN. Acesso em: 15 dez. 2014. KNIGH,T H. D.; SLEEPER, M. M. Fisiopatologia da insuficiência cardíaca. In: ABBOTT, J. A. Segredos em cardiologia de pequenos animais. Porto Alegre: Artmed. p. 24-45, 2006. KRAUT, E. J.; CHEN, S.; HUBBARD, N.E.; ERICKSON, K. L.; WISNER, D. H. Tumor necrosis factor depresses myocardial contractility in endotoxemic swine. Journal of Trauma. v. 46, n. 4, p. 900–906, 1999. 72 KVART, C.; HÄGGSTRÖM, J. Cardiopatia valvular adquirida. In: ETTINGER, S.J.; FELDMAN, E. C. Tratado de Medicina Interna Veterinária. Rio de Janeiro: Guanabara Koogan, 5ed., cap. 8, p. 833-46, 2004. LAREDO, F. Anesthesia in geriatric patients. Proceeding of the SEVC Southern European Veterinary Conference, Barcelona, Spain, 2009. Disponivel em: www.ivis.org. Acesso em 02/01/2015. LEDOUX, P. Cardiorenal syndrome. L`Avenir Medical Journal. v. 48, n. 8, p. 149-153, 1951. LEES, G. E. Early diagnosis of renal disease and renal failure. Veterinary Clinics of North America. Small Animal Practice. v. 34, n. 4, p. 867-885, 2004. LEES, G. E.; BROWN, S. A.; ELLIOTT, J.; GRAUER, G. F.; VADEN, S. L. Assessment and management of proteinuria in dogs and cats: 2004 ACVIM forum consensus statement (small animal). Journal of Veterinary Internal Medicine. v. 19, n. 4, p. 377–385, 2005. LEE, S. R.; JEONG, K. H. Novel Biomarkers for Cardio-renal Syndrome. Electrolyte & blood pressure. Heart Failure Reviews. v. 10, n. 1, p. 12-17, 2012. LJUNGVALL, I.; AHLSTROM, C.; HÖGLUND, K.; HULT, P.; KVART, C.; BORGARELLI, M.; ASK, P.; BORGARELLI, M.; HÄGGSTTRÖM, J. Use of signal analysis of heart sounds and murmurs to assess severity of mitral valve regurgitation attributable to myxomatous mitral valve disease in dogs. American Journal of Veterinary Research. v. 70, n. 5, p. 604-613, 2009. LOMBARD, C. W.; SPENCER, C. P. Correlation of Radiographic, echocardiographic and electrocardiographic signs of heart enlargement in dogs with mitral regurgitation. Veterinary Radiology. cap. 8, p. 26-89, 1985. LOPEZ-NOVOA, J. M.; RODRIGUES-PENA, A. B.; ORTIZ, A; MARTINEZSALGADO, C.; HERNANDEZ, F. J. L. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: Clinical implications. Journal of translational Medicine, v.9, p. 1-26, 2011. LOHSE, M. J.; VILARDAGA, J. P.; BÜNEMANN, M. Direct optical recording of intrinsic efficacy at a G protein-coupled receptor. Life Science. v. 74, n. 2–3, p. 397–404, 2003. MACFADYEN, R. J.; BARR, C. S.; STRUTHERS, A. D. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovascular Research. v. 35, n. 1, p. 30-34, 1997. MADY, C. Remodel, remodelment, remodelling. Arquivo Brasileiro de Cardiologia. v. 66, n. 2, p. 51-53, 1996. MAISEL, A.; MUELLER, C.; ADAMS, K.; ANKER, S. D.; ASPROMONTE, N.; CLELAND, J. G.; COHEN-SOLAL, A.; DAHLSTRONM, U.; DEMARIA, A.; DI 73 SOMMA, S.; FILIPPATOS, G, S.; FONAROW, G. C.; JOURDAIN, P.; KOMAJDA, M.; LIU, P. P.; MCDONAGH, T.; MCDONALD, K.; MEBAZZA, A.; NIEMINEN, M. S.; PEACOCK, W. F.; TUBARO, M.; VALLE, R.; VANDERHYDEN, M.; YANCY, C.; ZANNAD, F.; BRAUNNWALD, E. State of the art: Using natriuretic peptide levels in clinical practice. European Journal Heart Failure. v. 10, n5, p. 824-839, 2008. MARTELLI, A. Renin Angiotensin Aldosterone System and Cardiovascular Homeostasis. European Journal Heart Failure. v. 12, 51-55, 2010. MARTIN, M. Small Animal ECGs: An Introductory Guide. London: Blackwell Publishing, 2007. MARTINS, H.; NELSON, P.; CASTELLANO, M.; MONTEIRO, P.; MOURA, M. M.; PROVIDÊNCIA, L. A. Cardio-renal syndrome - The Challenge in Heart Failure Treatment. Acta Medica Portuguesa. v. 24, n. 2, p. 285-292, 2011. MARTÍNEZ-SANTOS, P.; VILACOSTA, I. Cardiorenal Syndrome: An Unsolved Clinical Problem. International Journal of Nephrology, n. 35, p. 44-47, 2011. McGROTTY, Y. Diagnosis and management of chronic kidney disease in dogs and cats. Companion Animal Practice, v.30, p.502-507, 2008. METRA, M.; NODARI, S.; PARRINELLO, G.; BORDONALI, T.; BUGATTI, S.; DANESI, R.; FONTANELLA, B.; LOMBARDI, C.; MILANI, P.; VERZURA, G.; GOTTER, G.; DITTRICH, H.; MASSIE, B. M.; DEI, CAS, L. Worsening renal func-tion in patients hospitalized for acute heart failure: clinical implications and prognostic significance. European Heart Journal. v. 10, p. 188-195, 2012. MERIC, S. M. Polyuria and Polydipsia. In: ETTINGER, S. L. Textbook of veterinary internal medicine. ed. 5, Saunder:Philadelphia, p. 85-90, 1995. MIRANDA, S. P.; MACEDO, R. N.; JUNIOR, G. B. S.; DAHER, E. F. Cardio-renal syndrome: pathophysiology and treatment. Revista da Associação Médico Brasileira, v. 55, n. 1, p: 89-94, 2009. MUZZI, R. A. L.; MUZZI, L. A. L.; ARAÚJO, R. B. Endocardiose da valva mitral: métodos de diagnóstico – revisão. Clínica Veterinária. v. 5, n. 27, p. 29-34, 2000. MUZZI, R. A.; DE ARAUJO, R. B.; MUZZI, L. A.; PENA, J. L.; SILVA, E. F. Regurgitant jet area by Doppler color flow mapping: quantitative assessment of mitral regurgitation severity in dogs. Journal of Veterinary Cardiology. v. 5, n. 2, p. 33-38, 2003. MULLENS, W.; ABRAHAMS, Z.; FRANCIS, G. S.; TAYLOR, D. O.; STARLIN, R. C.; YOUNG, J. B.; TANG, W. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. Journal of American College Cardiology. v. 53, n.8, p. 589–596, 2009. NABITY, M. B.; LEES, G. E.; DANGOTT, L. J.; CIANCIOLO, R.; SUCHODOLKI,J. S.; STEINER, J. M. Proteomic analysis of urine from male dogs during early stages of 74 tubulointerstitial injury in a canine e model of progressive glomerular disease. Veterinary Clinical Pathology. v. 40, p. 222-246, 2011. NABITY, M. B. New biomarkers of kidney disease: An Update. Annual American Colege of Veterinary Internal Medicine (ACVIM), New Orleands, 2012. NANAS, J. N.; MATSOUKA, C.; KARAGEORGOPOULOS, D.; LEONTI, A.; TSOLAKIS, E.; DRAKOS, S. G.; TSAGALOU, E. P.; MAROULIDIS, G. D.; ALEXOPOULOS, G. P.; KANAKAKIS, J. E.; ANASTASIOU-NANA, M. I. “Etiology of anemia in patients with advanced heart failure,” Journal of the American College of Cardiology, v. 48, n. 12, p. 2485–2489, 2006. NICOLLE, A. P.; CHETBOUL, V.; ALLERHEILIGEN, T.; POUCHELON, J. L.; GOUNI, V.; TESSIER-VETZEL, D.; SAMPEDRANO, C. C.; LEFEBVRE, H. P. Azotemia and glomerular filtration rate in dogs with chronic valvular disease. Journal of Veterinary Internal Medicine, n. 2, p. 943–949, 2007. OLIVAES, C. G. Estudos anatômico e clínico da técnica de anuloplastia valvar mitral por plicatura externa em cães. Dissertação de Mestrado em Cirurgia e Anestesiologia Veterinária – Universidade de Franca, 54f. Franca. 2010. OLSEN, L. H.; HÄGGSTRÖM, J.; PETERSEN, H. D. Acquired Valvular Heart Disease. In: ETTINGER, S. J.; FELDMAN, E. C. Textbook of veterinary internal medicine: diseases of the dog and the cat. ed. 7, St. Louis, Mo.: Elsevier Saunders, p. 1299-1314, 2010. OPIE, L. H. The neuroendocrinology of congestive heart failure. Cardiovascular Journal of Africa. v. 13, n. 4, 171-8, 2002. OYAMA, M. A. Neurohormonal activation in canine degenerative mitral valve disease: implications on pathophysiology and treatment. Journal Small Animal Practice. v. 50, p. 13-11, 2009. PADDLEFORD, R. R. Manual de anestesia em pequenos animais. ed. 2, São Paulo: Roca, p. 25-28, 2005. PEDERSEN, H. D.; KRISTENSEN, B.; NORBY, B.; LORENTZEN, K. A. Echocardiographic study of mitral valve prolapse in dachshunds. Zentralbl Veterinarmed. v. 43, n. 2, p. 103-110, 1999. PEDERSEN, H. D.; HÄGGSTRÖM, J. Mitral valve prolapse in the dog: a model of mitral valve prolapse in man. Cardiovascular Research. v. 47, p. 234-243, 2000. PEREIRA, P. M.; CAMACHO, A. A.; MORAIS, H. A. Tratamento de insuficiência cardíaca com benazepril em cães com cardiomiopatia dilatada e endocardiose. Arquivo Brasileiro de Medicina Veterinária Zootecnia. v.57, supl. 2, p.141-148, 2005. POLZIN, D. J.; OSBORNE, C. A.; STEVENS, J. B.; HAYDEN, D. W. Influence of modified protein diets on electrolyte, acid base, and divalent ion balance in dogs with 75 experimentally induced chronic renal failure. American Journal of Veterinary Research. n. 43, p. 1978-1986, 1982. POLZIN, D.; OSBORNE, C. A.; ROSS, S. Chronic kidney disease. In: ETTINGER, S. J.; FELDMAN, E. C. Textbook of Veterinary Internal Medicine. Philadelphia, PA: Saunders, ed. 6, cap. 17, p. 1766–1775, 2005. POLZIN, D. J.; OSBORNE, C. A.; BARTGES, J. W.; FINCO, D. R. Chronic kidney disease. In: ETTINGER, S. J.; FELDMAN, E. C. Textbook of veterinary internal medicine. St. Louis: Elsevier Saunders, p.1756-1785, 2005. POLZIN, D. J. Treating canine kidney disease: an evidence-based approach. Proceedings of the Hill`s NAVC&WVC Symposiums, p. 24-28, 2006. POLZIN, D. J. Diagnosing & staging kidney disease in dogs and cats, 2008. Disponível em: <www.chicagovma.org/pdfs/ceprograms/CVMA%20Notes.pdf. Acesso em: 10/12/2014. POLZIN, D. J.; OSBORNE, C. A.; ROSS, S. Evidence-Basead Managemment of Chronic Kidney Disease. In: BONAGURA, J. D.; TWEDT, D. C. Kirk`s current veterinary therapy XIV. St Louis, Missouri: Saunders Elsevier, p. 872-878, 2009. POLZIN, D. J. Chronic kidney disease. In: ETTINGER, S. J.; FELDMAN, E. C. Textbook of veterinary internal medicine. St. Louis:Elsevier Saunders, ed. 7, cap. 8, v.2, p. 1990-2021, 2010. POLZIN, D. J. Chronic kidney disease In: BARTGES, J.; POLZIN, D. J. Nephrology and urology of small animals. 2ed, cap. 5, p. 433–71, 2011. POLZIN, D. J. Evidence-basead step-wise approach to managing chronic kidney disease in dogs and cats. Journal of Veterinary Emergency and Critical Care. v. 23, n. 2, p. 205-215, 2013. PORCIELLO, F. Acquired Diseases, Echocardiography in the Dog, Cat and Horse. 2009. Disponível em: http:/www.vin.com/Members/Proceedings/Proceedings.plx?CID =ECHO 2007&Category=3903&PID=24127&O=VIN. Acesso em: 15 dez. 2014. POUCHELON, J.L.; KING, J.; MARTIGNONI, L.; CHETBOUL, V.; LUGARDON, B.; ROUSSELOT, J. F.;CORLOUER, J. P.; BUSSADORI, C.; PIETTE, M. H.; BROWNLIE, S.; MARTEL, P.; GARCIN, J. P.; HAGEN, A.; AMBERGER, C.; MARTIN, M.; LABADIE, F.; COLLET, M.; DROUARD, C.; LOMBARD, C.; HERVÉ, D.; STREHLAU, G. Long-term tolerability of benazepril in dogs with congestive heart failure. Journal Veterinary Cardiology. v. 6, n. 1, p. 7-13, 2004. POUCHELON, J. L.; JAMET, N.; GOUNI, V.; TISSIER, R.; SERRES, F.; SAMPEDRANO, C. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: a retrospective study of 141 cases. Journal of Veterinary Internal Medicine. v. 22, n. 4, p. 905-914, 2008. 76 POUCHELON, J. L.; ATKINS, C. E.; BUSSADORI, C.; OYAMA, M. A.; VADEN, S. L.; BONAGURA, J. D.; CHETBOUL, V.; COWGILL, L. D.; ELLIOT, J.; FRANCEY, T.; GRAUER, G. F.; LUIS FUENTES, V.; SYDNEY MOISE, N.; POLZIN, D. J.; VAN DONGEN, A. M.; VAN ISRAËL, N. Cardiovascular–renal axis disorders in the domestic dog and cat: a veterinary consensus statement. Journal of Small Animal Practice. n. 56, p. 537–552, 2015. PRICE, C. P.; NEWALL, R. G.; BOYD, J. C. Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: A systematic. Clinical Chemistry. Washington, v. 51, n. 9, p. 1-11, 2005. REINE, N. J.; LANGSTON, C. E. Urinalysis interpretation: how to squeeze out the maximum information from a small sample. Clinical Techniques in Small Animal Practice, Philadelphia, v. 20, n. 1, p. 2-10, 2005. REIS, L. M.; JORGETTI, V. Distúrbios do cálcio e do fósforo vasoativos. In: ZATZ, R. Série fisiopatologia clínica: Fisiopatologia renal. São Paulo:Atheneu, v. 2, p. 245-260, 2000. RENNKE, H. G.; DENKER, B. M. Sinais e sintomas da insuficiência renal crônica. In: RENNKE, H. G.; DENKER, B. M. Fisiopatologia renal, princípios básicos. 2ed. São Paulo: LMP, p.325-350, 2009. ROGERSON, F. M.; CHAI, S. Y.; SCHLAWE, I.; MURRAY, W. K.; MARLEY, P. D.; MENDELSOHN, F. A. Presence of angiotensin converting enzyme in the adventitia of large blood vessels. Journal of Hypertension. v. 10, n. 7, p. 615-620, 1992. RONCO, C.; HOUSE, A. A.; HAAPIO, M. Cardiorenal and renocardiac syndromes: the need for a comprehensive classification and consensus. Nature Clinical Practice Nephrology. v. 4, n. 2, p. 310–311, 2008. RONCO, C.; MCCULLOUGH, P.; ANKER, S. D.; ANAND, I.; BAGSHAW, S. W.; BELLOMO, R.; BERL, T.; BOBEK, I.; CRUZ, D. N.; DALIENTO, L.; DAVEMPORT, A.; HAAPIO, M.; HILLEGE, H.; HOUSE, A. A.; KATZ, N.; MAISEL, A.; MANKAD, S.; ZANCO, P.; MEBANZAA, A.; PALAZZOULI, A.; RONCO, F.; SHAW, A.; SHEINDFIELD, G.; SONI, G.; VESCOVO, G.; ZAMPERETTI, N.; PONIKOWSKI, P. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. European Heart Journal. v.31, n. 5, p. 703–711, 2010. RONCO, C. Cardiorenal syndromes: definition and classification. Contribuitions Nephrology. v. 164, n. 6, p.33–38, 2010. RONCO, C.; COZZOLINO, M. Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes. Heart Failure Reviews. v. 17, p. 211–220, 2012. ROSNER, M. H.; RASTOGI, A.; RONCO, C. The Cardiorenal Syndrome. Internation Journal of Nephrology, n. 57, p, 88-90, 2011. 77 RUBIN, S. I. Chronic renal failure and its management and nephrolithiasis. Veterinary Clinical North American of Small Animal Practice, n. 2, p. 1331-1354, 1997. RUGGENETI, P.; GASPARINI, F.; PERNA, A.; REMUZZI, G. Cross sectional longitudinal study of spot morning urine protein: Creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic disease in patients without diabetes. British Medical Journal, v. 316, p. 504-509, 1998. RUSH, J. E. Chronic valvular hearts disease in dogs. In: Proceedings of the 26th annual Waltham diets/OSU symposium. p. 1-7, 2002. RUSH, J. E. Chronic Valvular Disease in Dogs. In: BONAGURA, J. D.; TWEDT, D. C. Kirk’s Current Veterinary Therapy XIV, Small Animal Practice. Missouri: Saunders, p. 780-786, 2009. SHARMA, U. C.; POKHAREL, S.; VAN BRAKEL, T. J.; VAN BERLO, J. H.; CLEUTJENS, J. P.; SCHOROEN, B.; ANDRÉ, S.; CRIJNS, H. J.; GABIUS, H. J.; MAESSEN, J.; PINTO, Y. M. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation. v. 110, n. 9, p. 3121–3128, 2004. CHAMAS, P. P. C.; SALDANHA, I. R. R.; COSTA, R. L. O. Prevalência da doença degenerativa valvar crônica mitral em cães. Journal of Health Science Inst. v. 29, n. 3, p. 214-217, 2011. SAMAVAT, S.; AHMADPOOR, P.; SAMADIAN, F. Aldosterone, hypertension, and beyond. Iranian Journal of Kidney Diseases. v.5, n. 2, p. 71-76, 2011. SANDERSON, S. L. Measuring glomerular filtration rate: practical use of clearance tests. In: BONAGURA, J. D.; TWEDT, D. C. Kirk´s current veterinary therapy XIV. St. Louis: Saunders Elsevier, p. 872-879, 2009. SCHULLER, S.; VAN ISRAEL, N.; VANBELLE, S.; CLERCX, C.; MCENTEE, K. Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs. Journal of Veterinary Pharmacology Therapeutics. v. 34, n. 4, p. 322-331, 2011. SCHRIER, R. W.; ABRAHAM, W. T. Hormones and hemodynamics in heart failure. New England Journal Medicine. v. 341, n. 8, p. 577-85, 1999. SCHIFFRIN, E. L.; LIPMAN, M. L.; MANN, J. F. E. Chronic Kidney Disease. Circulation Research, Dallas, v. 116, p. 85-97, 2007. SETOGUCHI, S.; STEVENSON, L. W.; SCHNEEWEISS, S. Repeated hospitalizations predict mortality in the community population with heart failure. American Heart Journal. v. 154, n. 2, p. 260–6, 2007. SEYMOUR, A. A.; BURKETT, D. E.; ASAAD, M. M.; LANOCE, V. M.; CLEMONS, A. F.; ROGERS, W. L. Hemodynamic, renal, and hormonal effects of rapid ventricular pacing in conscious dogs. Laboratory Animal Science. v. 44, p. 443–452, 1994. 78 SEVEG, G. Proteinuria In: ETTINGER, S. J.; FELDMAN, E. C. Textbook of Veterinary Internal Medicine. California: Saunders Elsevier, 7ed., v. 1, p. 168-171, 2010. SMETS, P. M. Y.; MEYER, E.; MADDENS, B.; DUCHATEAU, L.; DAMINET, S.; Effects of sampling method and storage conditions on albumin, retinol-binding protein, and N-acetyl-ß- D-Glucosaminidase concentrations in canine urine samples. Journal of Veterinary Diagnostic Investigation. v. 22, p. 896-902, 2010. SILVA, R.; RIGBY, A. S.; WITTE, K. K.; NIKITIN, N. P.; TIN, L.; GOODE, K. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. American Journal of Cardiology. n. 98, p. 391-398, 2006. SILVERBERG, D. S.; WEXLER, D.; LAINA, A.; SCHWARTZ, D. The interaction between heart failure and other heart disease, and anemia. Seminars in Neprology, v. 26, n. 4, p. 296-306, 2006. SOARES, E. C.; LARSSON, M. H. M. A.; PINTO, C. F. Aspectos radiográficos da doença valvar crônica. Ciência Rural, Santa Maria, v.34, n.1, p.119-124, jan-fev, 2004. STEPIEN, R. L. Pathophysiology of hypertension and blood pressure assessment In: ETTINGER, S. J.; FELDMAN, E. C. Textbook of Veterinary Internal Medicine, v.1 seventh edition. California: saunders Elsevier, p. 577-581, 2011. STEVENS, L. A.; CORESH, J.; GREENE, T.; LEVEY, A. S. Assessing kidney function – Measured and estimated glomerular filtration rate. New England Journal of Medicine, n. 354, p. 2473-83, 2006. STEVENSON, L. W.; TILLISH, J. H. Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure. Circulation, n. 74, p. 1303-1308, 1986. STEVENSON, L. W.; NOHRIA, A.; MIELNICZUK, L. Torrent or torment from the tubules? Challenge of the cardiorenal connections. Journal American College of Cardiology. v. 45, n. 7, p. 2004–2007, 2005. STRAETER-KNOWLEN, I. M.; DELL'ITALIA, L. J.; DAI, J.; HANKES, G. H.; DILLON, A. R.; CARTEE, R. E. ACE inhibitors in HF restore canine pulmonary endothelial function and ANG II vasoconstriction. American Journal Physiology. v. 277, p. 19-25, 1999. STOCKHAM, S. L.; SCOTT, M. A. Urinary system. In: Fundamentals of veterinary clinical pathology. Iowa: Iowa State Press, cap.8. p.279-334, 2002. SUTER, P. F. Thoracic Radiography: An Atlas of Thoracic Diseases in the Dog and Cat. 3ed., p. 99-110, 1984. SYME, M. H. Poliúria e Polidipsia. In: ELLIOTT, J.; GRAUER, F. G. Manual de Nefrologia e Urologia de Cães e Gatos. Roca: São Paulo; Cap. 2; p. 9-28, 2007. 79 SYME, H. M. Proteinuria in cats – prognostic marker or mediator? Journal of Feline Medicine and Surgery. London, v. 11, n. 3, p. 211-218, 2009. SYME, H. Hypertension in small animal kidney disease. Veterinary clinical of north america: small animal practice. v.41, p. 63-89, 2011. SWENSON, L. Relationship between parental cardiac status in Cavalier King Charles spaniels and prevalence and severity of chronic valvular disease in offspring. Journal American Veterinary Medical Association v. 208, n. 12, p. 2009-2012, 1996. SCHRIER, R. W.; ABRAHAM, W. T. Hormones and hemodynamics in heart failure. New England Journal Medicine. v. 341, n. 8, p. 577-585, 1999. TANG, W. H.; MULLENS, W. Cardio-renal syndrome in decompensated heart failure. 2009. Disponível em: http://dx.doi.org/10.1136/hrt.2009.166256. Acesso em: 15 dez. 2014. TESTANI, J. M.; KHERA, A. V.; SUTTON, M. G.; KEANE, M. G.; WIEGERS, S. E.; SHANNON, R. P.; KIRKPATRICK, J. N. Effect of Right Ventricular Function and Venous Congestion on Cardiorenal Interactions During the Treatment of Decompensated Heart Failure. American Journal of Cardiology. v. 105, n. 4, p. 511-516, 2010. TILLEY, L. P.; GOODWIN, J. K. Manual de cardiologia para cães e gatos, ed. 3, São Paulo:Roca, p. 34-36, 2002. UECHI, M.; SHIMIZU, A.; MIZUNO, M. Heart rate modulation by sympathetic nerves in dogs with heart failure. Journal of Veterinary Medicine Scienci. v. 64, n. 11, p. 1023-1029, 2002. UTHOFF, H.; BREIDTHARDT, T.; KLIMA, T.; ASCHWANDEN, M.; ARENJA, N.; SOCRATES, T.; HEINISCH, C.; NOVEANU, M.; FRISCHKNECHET, B.; BAUMANN, U.; JAEGER, K. A.; MUELLER, C. Central venous pressure and impaired renal function in patients with acute heart failure. European Journal of Heart Failure. v. 13, n. 3, p. 432–439, 2011. VIRZI, G.; CRUZ, D. N.; BOLIN, C.; VESCOVO, G.; RONCO, C. Immunomediated mechanisms of organ damage in cardiorenal syndrome type 1. European Nephrology. v. 6, n. 2, p. 25-29, 2012. VISWANATHA, N. G.; GILBERT, S. The Cardiorenal Syndrome: Making the Connection. International Journal Nephrology, 2011. doi:10.4061/2011/283137. WARE, W. A.; LUND, D. D.; SUBIETA, A. R.; CHMID, P. G. Sympathetic activation in dogs with congestive heart failure caused by chronic mitral valve disease and dilated cardiomyopathy. Journal American Veterinary Medical Association. v. 197, n. 11, p. 1475-1481, 1990. WARE, W. A. Acquired Valvular and Endocardial Disease. In: NELSON, R. W.; COUTO, C. G. Small Animal Internal Medicine. 4ed. St. Louis: Mosby Elsevier, p. 141-127, 2009. 80 WARE, W. Acquired Valve Diseases. In: WARE, W., Cardiovascular Disease in Small Animal Medicine. Manson Publishing Ltd. 2ed, p. 198-216, 2007. WATSON, A. D. Indicators of renal insufficiency in dogs and cats presented at a veterinary teaching hospital. Australian Veterinary Practitioner, Hurstville, v. 31, n. 2, p. 54-58, 2003. YU, L.; BURDMANN, E.; SEGURO, A.C.; HELOU, C. M. B.; ZATS, R. Insuficiência renal aguda. In: ZATS, R. Fisiopatologia renal. São Paulo: Ed. Atheneu, v.2, cap. 5, p.261-282, 2000. WHITE, J. V.; OLIVIER, N. B.; REIMANN, K.; JOHNSON, C. Use of proteintocreatinine ratio in a single specimen for quantitative estimation of canine proteinuria. Journal of the American Veterinary Medical Association, v. 185, p. 882-885, 1984. YOSIDA, K.; YOSHIKAWA, J.; SHAKUDO, M.; AKASAKA, T.; JYO, Y.; TAKAO, S. Colour Doppler evaluation of valvular regurgitation in normal subjects. Circulation Research. 78: 840-847, 1988. ZADRAZIL, J.; HORAK, P. Pathophysiology of anemia in chronic kidney disease. A review. Biomedical papers of the Medical Faculty of the University PalacKý. v. 158, 2014. ZANNAD, F.; ALLA, F.; DOUSSET, B.; PITT, B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation. v. 102, n. 22, p. 2700-2706, 2000. ZATZ, R. Fisiopatologia renal. In: REIS, L. M.; JORGETTI, V. Distúrbios do cálcio e do fósforo. ed. 2, São Paulo: Atheneu, p. 245-60, 2002.por
dc.subject.cnpqMedicina Veterináriapor
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/10455/2015%20-%20Rosemar%20de%20Almeida%20Freitas.pdf.jpg*
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/16332/2015%20-%20Rosemar%20de%20Almeida%20Freitas.pdf.jpg*
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/22636/2015%20-%20Rosemar%20de%20Almeida%20Freitas.pdf.jpg*
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/29016/2015%20-%20Rosemar%20de%20Almeida%20Freitas.pdf.jpg*
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/35368/2015%20-%20Rosemar%20de%20Almeida%20Freitas.pdf.jpg*
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/41764/2015%20-%20Rosemar%20de%20Almeida%20Freitas.pdf.jpg*
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/48166/2015%20-%20Rosemar%20de%20Almeida%20Freitas.pdf.jpg*
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/54618/2015%20-%20Rosemar%20de%20Almeida%20Freitas.pdf.jpg*
dc.originais.urihttps://tede.ufrrj.br/jspui/handle/jspui/2850
dc.originais.provenanceSubmitted by Celso Magalhaes (celsomagalhaes@ufrrj.br) on 2019-08-30T13:31:53Z No. of bitstreams: 1 2015 - Rosemar de Almeida Freitas.pdf: 1268523 bytes, checksum: fad293b658f721a446511345b71ab496 (MD5)eng
dc.originais.provenanceMade available in DSpace on 2019-08-30T13:32:54Z (GMT). No. of bitstreams: 1 2015 - Rosemar de Almeida Freitas.pdf: 1268523 bytes, checksum: fad293b658f721a446511345b71ab496 (MD5) Previous issue date: 2019-02-14eng
Appears in Collections:Mestrado em Medicina Veterinária (Patologia e Ciências Clínicas)

Se for cadastrado no RIMA, poderá receber informações por email.
Se ainda não tem uma conta, cadastre-se aqui!

Files in This Item:
File Description SizeFormat 
2015 - Rosemar de Almeida Freitas.pdfRosemar de Almeida Freitas.1.24 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.